Quinodoz Mathieu, Iglesias-Romero Ana Belén, Cancellieri Francesca, Kaminska Karolina, Scholl Hendrik P N, Pfau Maximilian, Rivolta Carlo
Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Department of Ophthalmology, University of Basel, Basel, Switzerland.
Adv Exp Med Biol. 2025;1468:57-62. doi: 10.1007/978-3-031-76550-6_10.
Stargardt disease (STGD1) is an inherited retinal dystrophy that follows an autosomal recessive inheritance in which photoreceptors degenerate, leading to progressive vision loss that starts from the central retina. The severity of symptoms can vary considerably depending on the mutations: they range from severe childhood-onset to late-onset milder forms, the latter being caused by specific hypomorphic variants. In this study, we describe a novel non-canonical splicing variant: NM_000350.3:c.5461-6T>C. This variant was found in compound heterozygosity with a frequent pathogenic hypomorphic variant, p.Gly1961Glu, in a patient with Stargardt disease and her affected brother. In silico tools predicted a low effect on splicing, but experimental validation, in contrast, showed this DNA change to be causing severe splicing alterations.
斯塔加特病(STGD1)是一种遗传性视网膜营养不良症,遵循常染色体隐性遗传模式,其中光感受器会退化,导致从视网膜中央开始的渐进性视力丧失。症状的严重程度会因突变而有很大差异:从严重的儿童期发病到较温和的迟发性形式,后者由特定的低表达变体引起。在本研究中,我们描述了一种新的非典型剪接变体:NM_000350.3:c.5461-6T>C。在一名斯塔加特病患者及其患病兄弟中,发现该变体与常见的致病性低表达变体p.Gly1961Glu呈复合杂合状态。计算机工具预测该变体对剪接的影响较小,但实验验证表明,这种DNA变化会导致严重的剪接改变。